Hacker News new | past | comments | ask | show | jobs | submit login

Look at the five-year charts for Moderna and BioNTech and it's pretty clear they've gone back to a more normal valuation.



Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: